| Erythropoiesis: model systems, molecular regulators, and developmental programs AS Tsiftsoglou, IS Vizirianakis, J Strouboulis IUBMB life 61 (8), 800-830, 2009 | 220 | 2009 |
| Mechanisms involved in the induced differentiation of leukemia cells AS Tsiftsoglou, IS Pappas, IS Vizirianakis Pharmacology & therapeutics 100 (3), 257-290, 2003 | 201 | 2003 |
| Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver A Arora, K Seth, Y Shukla Carcinogenesis 25 (6), 941-949, 2004 | 125 | 2004 |
| Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes IS Vizirianakis Nanomedicine: Nanotechnology, Biology and Medicine 7 (1), 11-17, 2011 | 93 | 2011 |
| Controlled release of 5-fluorouracil from microporous zeolites M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014 | 77 | 2014 |
| Lipid-like self-assembling peptide nanovesicles for drug delivery DG Fatouros, DA Lamprou, AJ Urquhart, SN Yannopoulos, IS Vizirianakis, ... ACS applied materials & interfaces 6 (11), 8184-8189, 2014 | 70 | 2014 |
| Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriers M Filippousi, S Turner, K Leus, PI Siafaka, ED Tseligka, M Vandichel, ... International journal of pharmaceutics 509 (1-2), 208-218, 2016 | 65 | 2016 |
| Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine IS Vizirianakis European Journal of Pharmaceutical Sciences 15 (3), 243-250, 2002 | 62 | 2002 |
| Microfluidic transport in microdevices for rare cell capture JP Smith, AC Barbati, SM Santana, JP Gleghorn, BJ Kirby Electrophoresis 33 (21), 3133-3142, 2012 | 45 | 2012 |
| Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation E Sayed, C Karavasili, K Ruparelia, R Haj-Ahmad, G Charalambopoulou, ... Journal of Controlled Release 278, 142-155, 2018 | 42 | 2018 |
| Synthesis, molecular structure determination, and antitumor activity of platinum (II) and palladium (II) complexes of 2-substituted benzimidazole. S Mylonas, A Valavanidis, K Dimitropoulos, M Polissiou, AS Tsiftsoglou, ... Journal of inorganic biochemistry 34 (4), 265-275, 1988 | 41 | 1988 |
| Modified chitosan coated mesoporous strontium hydroxyapatite nanorods as drug carriers M Filippousi, PI Siafaka, EP Amanatiadou, SG Nanaki, M Nerantzaki, ... Journal of Materials Chemistry B 3 (29), 5991-6000, 2015 | 36 | 2015 |
| Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells IS Vizirianakis, YQ Chen, SS Kantak, AS Tsiftsoglou, RH Kramer International journal of oncology 21 (1), 135-144, 2002 | 36 | 2002 |
| Development of new drug delivery system based on ordered mesoporous carbons: characterisation and cytocompatibility studies C Karavasili, EP Amanatiadou, L Sygellou, DK Giasafaki, TA Steriotis, ... Journal of Materials Chemistry B 1 (25), 3167-3174, 2013 | 35 | 2013 |
| Development of a nanoporous and multilayer drug-delivery platform for medical implants V Karagkiozaki, E Vavoulidis, PG Karagiannidis, M Gioti, DG Fatouros, ... International journal of nanomedicine 7, 5327, 2012 | 35 | 2012 |
| Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives IS Vizirianakis, M Chatzopoulou, ID Bonovolias, I Nicolaou, ... Journal of medicinal chemistry 53 (19), 6779-6810, 2010 | 33 | 2010 |
| Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma M Kyrodimou, D Andreadis, A Drougou, EP Amanatiadou, L Angelis, ... Clinical oral investigations 18 (1), 199-210, 2014 | 31 | 2014 |
| Expression of ribosomal protein S5 cloned gene during differentiation and apoptosis in murine erythroleukemia (MEL) cells. IS Vizirianakis, IS Pappas, D Gougoumas, AS Tsiftsoglou Oncology research 11 (9), 409-419, 1999 | 30 | 1999 |
| Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice IS Vizirianakis Current drug delivery 1 (1), 73-80, 2004 | 28 | 2004 |
| The developmental program of murine erythroleukemia cells AS Tsiftsoglou, IS Pappas, IS Vizirianakis Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 13 …, 2003 | 28 | 2003 |
